642 related articles for article (PubMed ID: 19153092)
1. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
2. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.
Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS
Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040
[TBL] [Abstract][Full Text] [Related]
3. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
4. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
Mulders AG; Laven JS; Eijkemans MJ; de Jong FH; Themmen AP; Fauser BC
Hum Reprod; 2004 Sep; 19(9):2036-42. PubMed ID: 15217995
[TBL] [Abstract][Full Text] [Related]
5. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
[TBL] [Abstract][Full Text] [Related]
8. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
9. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
10. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
11. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
12. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure.
Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P
Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888
[TBL] [Abstract][Full Text] [Related]
15. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
16. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
[TBL] [Abstract][Full Text] [Related]
17. Hormone and Sperm Analyses after Chemo- and Radiotherapy in Childhood and Adolescence.
Rendtorff R; Hohmann C; Reinmuth S; Müller A; Dittrich R; Beyer M; Wickmann L; Keil T; Henze G; Borgmann-Staudt A
Klin Padiatr; 2010 May; 222(3):145-9. PubMed ID: 20514617
[TBL] [Abstract][Full Text] [Related]
18. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone.
Gubbels CS; Kuppens SM; Bakker JA; Konings CJ; Wodzig KW; de Sain-van der Velden MG; Menheere PP; Rubio-Gozalbo ME
Fertil Steril; 2009 Apr; 91(4):1293.e13-6. PubMed ID: 19200962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
